Pharma Industry News

MSD’s Keytruda doubles PFS in bowel cancer subset

The 'game-changing' results will likely result in a paradigm shift in current clinical practice, researchers saidOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]